Koji Yoshimoto

Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors

Ingo K. Mellinghoff, Maria Y. Wang, Igor Vivanco et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Medicine, Molecular Medicine, Oncology +16

Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu et al. · PLoS Medicine · 2008 · 591 citations · Full text

Medicine, Oncology, Pharmacology +14

Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades

Osamu Togao, Takashi Yoshiura, Jochen Keupp et al. · Neuro-Oncology · 2013 · 396 citations · Full text

Medicine, Neuroscience, Radiology +17

Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain

Jeffrey C. Lee, Igor Vivanco, Rameen Beroukhim et al. · PLoS Medicine · 2006 · 369 citations · Full text

Medicine, Cancer Biology, Oncology +17

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 265 citations · Full text

Medicine, Oncology, Radiation Oncology +17